Table 7.
Significant microRNAs expression as average fold change = (2-ΔΔCT) in the liver cirrhosis group vs the hepatocellular carcinoma group
MiRNA name | HCC | LC | Fold change | Log2 fold change | P value |
hsa-miR-23b-3p | 2.44 | 0.78 | 0.32 | -1.64 | 0.001a |
hsa-miR-34a | 1.88 | 0.16 | 0.09 | -3.47 | 0.001a |
hsa-miR-122-5p | 0.34 | 0.98 | 0.12 | 2.87 | 0.001a |
hsa-miR-198 | 0.88 | 0.29 | 0.33 | -4.64 | 0.001a |
hsa-miR-199a-3p | 1.18 | 0.31 | 0.26 | -1.94 | 0.001a |
hsa-miR-221 | 1.13 | 3.31 | 2.92 | 1.55 | 0.001a |
P < 0.005 with ± 1.5 log2 fold expression change. HCC: Hepatocellular carcinoma; LC: Liver cirrhosis; miRNA: MicroRNA.